Page last updated: 2024-10-30

lamotrigine and Bone Diseases, Developmental

lamotrigine has been researched along with Bone Diseases, Developmental in 2 studies

Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.

Research Excerpts

ExcerptRelevanceReference
"To determine whether long-term treatment with valproate (VPA) and/or lamotrigine (LTG) in children with epilepsy is associated with altered growth and/or bone metabolism."7.71Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. ( Atkinson, SA; Guo, CY; Ronen, GM, 2001)
"To determine whether long-term treatment with valproate (VPA) and/or lamotrigine (LTG) in children with epilepsy is associated with altered growth and/or bone metabolism."3.71Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. ( Atkinson, SA; Guo, CY; Ronen, GM, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, HS1
Wang, SY1
Salter, DM1
Wang, CC1
Chen, SJ1
Fan, HC1
Guo, CY1
Ronen, GM1
Atkinson, SA1

Other Studies

2 other studies available for lamotrigine and Bone Diseases, Developmental

ArticleYear
The impact of the use of antiepileptic drugs on the growth of children.
    BMC pediatrics, 2013, Dec-19, Volume: 13

    Topics: Adolescent; Anticonvulsants; Body Height; Bone Diseases, Developmental; Calcium; Carbamazepine; Cell

2013
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Epilepsia, 2001, Volume: 42, Issue:9

    Topics: Adolescent; Anticonvulsants; Bone and Bones; Bone Density; Bone Diseases, Developmental; Bone Diseas

2001